Cargando…

Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction

OBJECTIVE: The rs10757278, rs1333049 and rs4977574 are single nucleotide polymorphisms (SNPs) of chromosome 9p21 locus associated with a prevalence of acute coronary syndromes (ACS). Reports concerning their association with long-term outcome after an ACS are equivocal. The aim of our study was to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Szpakowicz, Anna, Kiliszek, Marek, Pepinski, Witold, Waszkiewicz, Ewa, Franaszczyk, Maria, Skawronska, Małgorzata, Ploski, Rafal, Niemcunowicz-Janica, Anna, Dobrzycki, Sławomir, Opolski, Grzegorz, Musial, Włodzimierz Jerzy, Kaminski, Karol Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126747/
https://www.ncbi.nlm.nih.gov/pubmed/25105296
http://dx.doi.org/10.1371/journal.pone.0104635
_version_ 1782329960023719936
author Szpakowicz, Anna
Kiliszek, Marek
Pepinski, Witold
Waszkiewicz, Ewa
Franaszczyk, Maria
Skawronska, Małgorzata
Ploski, Rafal
Niemcunowicz-Janica, Anna
Dobrzycki, Sławomir
Opolski, Grzegorz
Musial, Włodzimierz Jerzy
Kaminski, Karol Adam
author_facet Szpakowicz, Anna
Kiliszek, Marek
Pepinski, Witold
Waszkiewicz, Ewa
Franaszczyk, Maria
Skawronska, Małgorzata
Ploski, Rafal
Niemcunowicz-Janica, Anna
Dobrzycki, Sławomir
Opolski, Grzegorz
Musial, Włodzimierz Jerzy
Kaminski, Karol Adam
author_sort Szpakowicz, Anna
collection PubMed
description OBJECTIVE: The rs10757278, rs1333049 and rs4977574 are single nucleotide polymorphisms (SNPs) of chromosome 9p21 locus associated with a prevalence of acute coronary syndromes (ACS). Reports concerning their association with long-term outcome after an ACS are equivocal. The aim of our study was to investigate the association of the 9p21.3 locus with 5-year overall mortality in patients with ST-elevation myocardial infarction (STEMI). MATERIALS AND METHODS: We performed a retrospective analysis of data collected prospectively in 2 independent registries of consecutive patients with STEMI (derivation and validation group). Genotyping was performed with the TaqMan method. The analyzed end-point was total mortality. RESULTS: The derivation group comprised 589 patients: 25.3% female (n = 149), mean age 62.4±12.0 years, total 5-year mortality 16.6% (n = 98). When all the study group was analyzed, no significant differences in mortality were found between the genotypes. However, in high-risk patients (GRACE risk score ≥155 points, n = 238), homozygotes associated with higher risk for ACS had significantly better 5-year survival compared to other genotypes. The hazard ratio associated with the high-risk genotype (a homozygote of high risk for ACS or a heterozygote) was: HR = 2.2 (1.15–4.2) for the rs10757278 polymorphism, HR = 2.7 (95% CI 1.3–5.4) for the rs4977574 one and HR = 2.3 (1.2–4.5) for the rs1333049 one (Cox proportional hazards model). Survival analysis in the validation group (n = 365) showed a clear trend towards better prognosis in GG homozygotes of the rs10757278 SNP, which confirms our initial results (p = 0.09, log-rank test). CONCLUSIONS: The 9p21.3 locus is associated with 5-year mortality in high-risk patients with STEMI. The genotypes associated with higher risk for ACS show a protective effect in terms of further survival (instead of a deteriorating prognosis, as reported previously). This finding, due to the very high size of the effect, could potentially be applied to clinical practice, if appropriate methods are elaborated.
format Online
Article
Text
id pubmed-4126747
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41267472014-08-12 Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction Szpakowicz, Anna Kiliszek, Marek Pepinski, Witold Waszkiewicz, Ewa Franaszczyk, Maria Skawronska, Małgorzata Ploski, Rafal Niemcunowicz-Janica, Anna Dobrzycki, Sławomir Opolski, Grzegorz Musial, Włodzimierz Jerzy Kaminski, Karol Adam PLoS One Research Article OBJECTIVE: The rs10757278, rs1333049 and rs4977574 are single nucleotide polymorphisms (SNPs) of chromosome 9p21 locus associated with a prevalence of acute coronary syndromes (ACS). Reports concerning their association with long-term outcome after an ACS are equivocal. The aim of our study was to investigate the association of the 9p21.3 locus with 5-year overall mortality in patients with ST-elevation myocardial infarction (STEMI). MATERIALS AND METHODS: We performed a retrospective analysis of data collected prospectively in 2 independent registries of consecutive patients with STEMI (derivation and validation group). Genotyping was performed with the TaqMan method. The analyzed end-point was total mortality. RESULTS: The derivation group comprised 589 patients: 25.3% female (n = 149), mean age 62.4±12.0 years, total 5-year mortality 16.6% (n = 98). When all the study group was analyzed, no significant differences in mortality were found between the genotypes. However, in high-risk patients (GRACE risk score ≥155 points, n = 238), homozygotes associated with higher risk for ACS had significantly better 5-year survival compared to other genotypes. The hazard ratio associated with the high-risk genotype (a homozygote of high risk for ACS or a heterozygote) was: HR = 2.2 (1.15–4.2) for the rs10757278 polymorphism, HR = 2.7 (95% CI 1.3–5.4) for the rs4977574 one and HR = 2.3 (1.2–4.5) for the rs1333049 one (Cox proportional hazards model). Survival analysis in the validation group (n = 365) showed a clear trend towards better prognosis in GG homozygotes of the rs10757278 SNP, which confirms our initial results (p = 0.09, log-rank test). CONCLUSIONS: The 9p21.3 locus is associated with 5-year mortality in high-risk patients with STEMI. The genotypes associated with higher risk for ACS show a protective effect in terms of further survival (instead of a deteriorating prognosis, as reported previously). This finding, due to the very high size of the effect, could potentially be applied to clinical practice, if appropriate methods are elaborated. Public Library of Science 2014-08-08 /pmc/articles/PMC4126747/ /pubmed/25105296 http://dx.doi.org/10.1371/journal.pone.0104635 Text en © 2014 Szpakowicz et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Szpakowicz, Anna
Kiliszek, Marek
Pepinski, Witold
Waszkiewicz, Ewa
Franaszczyk, Maria
Skawronska, Małgorzata
Ploski, Rafal
Niemcunowicz-Janica, Anna
Dobrzycki, Sławomir
Opolski, Grzegorz
Musial, Włodzimierz Jerzy
Kaminski, Karol Adam
Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction
title Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction
title_full Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction
title_fullStr Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction
title_full_unstemmed Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction
title_short Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction
title_sort polymorphism of 9p21.3 locus is associated with 5-year survival in high-risk patients with myocardial infarction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126747/
https://www.ncbi.nlm.nih.gov/pubmed/25105296
http://dx.doi.org/10.1371/journal.pone.0104635
work_keys_str_mv AT szpakowiczanna polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction
AT kiliszekmarek polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction
AT pepinskiwitold polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction
AT waszkiewiczewa polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction
AT franaszczykmaria polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction
AT skawronskamałgorzata polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction
AT ploskirafal polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction
AT niemcunowiczjanicaanna polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction
AT dobrzyckisławomir polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction
AT opolskigrzegorz polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction
AT musialwłodzimierzjerzy polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction
AT kaminskikaroladam polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction